Marksans Pharma Share price

MARKSANS

Healthcare Mid

190.38

8.30 (4.56%)

NSE

BSE

Last updated on 3 Nov, 2025 | 15:59 IST

BUYSELL

Today's High

194.80

Today's Low

180.51

52 Week Low

162.00

52 Week High

358.70 The current prices are delayed, login to your account for live prices

Marksans Pharma Share Key Metrics

Volume

36.37 L

Market Cap

8629.71 CR

LTQ@LTP

17@190.38

ATP

190.58 Var Margin

22.34 %

Circuit Range

145.66-218.49

Delivery %

42.32 %

Value

69.32 CR

ASM/GSM

No

Market Lot

1

Marksans Pharma Fundamentals

P/E Ratio

23.55

P/B Ratio

3.27

Div. Yield

0.44

Sector P/E

36.86

Sector P/B

3.52

Sec. Div. Yield

0.55

Marksans Pharma Resistance and Support

Pivot 248.68

Resistance

First Resistance

255.26

Second Resistance

262.58

Third Resistance

269.16

Support

First Support

241.36

Second Support

234.78

Third Support

227.46

Marksans Pharma Futures & Options

Data Not Found

Marksans Pharma Shareholding Pattern

2016-17
2018-19
2019-20
2020-21
2021-22
2022-23
2023-24
2024-25
2025-26

Total Promoters

Segment

Percent

Total Promoters

43.87%

Mutual Fund

3.92%

Insurance

0%

Foreign Institutional Investors

16.92%

Domestic Institutional Investors

1.36%

Retail

33.93%

Others

0%

Total Promoters

MAR '25

43.87%

JUN '25

43.87%

SEP '25

43.87%

Marksans Pharma Corporate Actions

Date	Agenda
2025-11-13	Quarterly Results
2025-08-12	Quarterly Results
2025-05-19	Audited Results & Final Dividend
2025-02-11	Quarterly Results
2024-11-12	Quarterly Results
2024-08-13	Quarterly Results

Marksans Pharma News

Marksans Pharma stock skyrockets 13% on strong all-round Q1 earnings show

Aug 14 2024 12:31:54

NSE : 10579

BSE : 524404

ISIN : INE750C01026

Marksans Pharma Management

Name	Position
Mr. Mark Saldanha	Chairman & Managing Director
Mrs. Sandra Saldanha	Whole Time Director

Marksans Pharma Similar Stocks

Jupiter Life Line Hospitals Ltd.

1568.00

-20.30 (1.28%)

Metropolis Healthcare Ltd.

2007.40

37.00 (1.88%)

Vijaya Diagnostic Centre Ltd.

1019.70

31.05 (3.14%)

Procter & Gamble Health Ltd.

6085.50

-81.00 (1.31%)

Strides Pharma Science Ltd.

984.80

50.10 (5.36%)

Aarti Pharmalabs Ltd.

858.00

6.05 (0.71%)

Yatharth Hospital & Trauma Care Services Ltd.

814.10

17.85 (2.24%)

FDC Ltd.

460.15

-0.50 (0.11%)

Thyrocare Technologies Ltd.

1381.30

-16.00 (1.15%)

Akums Drugs & Pharmaceuticals Ltd.

467.65

6.90 (1.50%)

Marksans Pharma FAQs

The Buying Price of Marksans Pharma share is 190.38 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Marksans Pharma stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Marksans Pharma, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Marksans Pharma shares is 23.55. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Marksans Pharma shares is 3.27. Useful to assess the stock's value relative to its book value.

To assess Marksans Pharma’s valuation compare Sector P/E, P/B which are 36.86 & 3.52 with sector averages, along with growth rates and financial metrics.

The Market Cap of Marksans Pharma is 8629.71 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Marksans Pharma share price is 358.70 & 162.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Marksans Pharma belongs to the Healthcare sector.